The Manager of CMC Program Operations will lead digital enablement and operational strategy by designing AI-driven tools to automate reporting and improve program visibility. They will also manage integrated project plans, track regulatory commitments, and facilitate cross-functional coordination across CMC workstreams.
The Regional Scientific Director establishes trusted partnerships with healthcare professionals to provide scientific education on CRISPR-based gene editing programs. They also support Phase 3 clinical trial activities, including site activation, recruitment, and addressing operational barriers.
The Strategic Account Liaison will lead site assessment, readiness, and activation strategies to ensure treatment centers can successfully administer CRISPR-based therapies. This role involves managing complex care pathways, coordinating with healthcare providers, and navigating reimbursement processes to ensure seamless patient access.
The role is responsible for setting and executing the integrated evidence strategy to demonstrate value and enable durable access for gene editing therapies. This includes leading the Field HEOR team to drive payer engagement and informing U.S. coverage and reimbursement decisions.
Define and execute the enterprise-wide quality vision and strategy to support growth from clinical development through commercial operations. Lead digital transformation through eQMS implementation and ensure global regulatory compliance and inspection readiness.
